Clinical trial Recruiting at 1 site Interventional Ages 21 to 75

Measuring defecation mechanics in people with outlet obstruction constipation

Official title: Understanding Defecation Patterns Using a Novel Device (Fecobionics) to Improve Treatment of Constipation

Run by The California Medical Innovations Institute, Inc. · NCT04903470 · Data updated 2026-11-12

This test uses a stool-like device called Fecobionics to see if it can measure muscle and pressure changes during bowel movements in people with outlet obstruction and in healthy volunteers.

More Gastric Outlet Obstruction trials

Quick facts

Study typeInterventional
Ages21 Years to 75 Years
SexAll
Enrollment130 (estimated)
SponsorThe California Medical Innovations Institute, Inc.
Academic / other
Drugs / interventionsradiation
Locations2 sites (San Diego, California and 1 other locations)
StatusRecruiting
StartedDecember 19, 2022
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 21, 2025
Trial IDNCT04903470 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with chronic constipation due to outlet obstruction by Rome IV criteria, and healthy adults with normal daily or alternate-day bowel movements without excessive straining, who can consent and undergo the tests are ideal candidates.

Probably not a fit

People with concurrent fecal incontinence, recent anorectal surgery or bowel resection, major chronic diseases, pregnancy, or those taking medications that affect anorectal function are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses an electronic simulated stool (Fecobionics) that records pressures, cross-sectional area, orientation, bending, and shape as it is expelled to mimic natural defecation. Investigators will combine Fecobionics with abdominal wall and external anal sphincter EMG and high-frequency rectal ultrasound to separate contributions from abdominal and rectal muscle activity. Separate experiments include pharmacologic manipulation with atropine to block rectal smooth muscle and use of bisacodyl as needed for expulsion challenges, enrolling healthy volunteers and patients meeting Rome IV criteria for obstructed defecation. Data will compare spatiotemporal patterns of pressure and muscle activity between groups to define rectal peristalsis and the defecatory reflex.

Why it matters

Potential benefit: If successful, this device could improve diagnosis of defecatory disorders and guide development of more targeted treatments for obstructed defecation.

How similar studies have gone: This Fecobionics approach is relatively novel and comprehensive simultaneous recordings of pressure, shape, and muscle activity during defecation are limited clinically, so the method is largely untested in broad patient populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Two groups of subjects will be studied - normal healthy subjects and patients with chronic constipation.

Normal subjects:

Inclusion criteria \*Normal defecation pattern, i.e., bowel movement once every day or other day without excessive straining and sense of complete evacuation.

Exclusion Criteria:

* Subjects not willing to consent and undergo the specified tests in this study
* Pregnant women
* Subjects with concurrent fecal incontinence and constipation symptoms
* Chronic diseases
* Taking medications that affect anorectal function
* History of anorectal surgery or bowel resection.

Constipation patients:

Inclusion Criteria:

* Rome IV diagnostic criteria will be used to diagnose chronic constipation. Patients must have experienced at least two of the following symptoms over the preceding 3 months:

  1. Fewer than three spontaneous bowel movements per week,
  2. Straining for more than 25% of defecation attempts,
  3. Lumpy or hard stools for at least 25% of defecation attempts, and
  4. sensation of anorectal obstruction or blockage.

     \-

     Exclusion Criteria:
* Patients not willing to consent and undergo the specified tests in this study
* pregnant women and patients with concurrent fecal incontinence
* History of anorectal surgery or bowel resection.

Where it's running

  • Augusta University Medical Center
    Augusta, Georgia, United States
    Recruiting
  • California Medical Innovations Institute
    San Diego, California, United States
    Active not recruiting

Study contacts

  • Principal investigator: Hans Gregersen, MD, PhD — California Medical Innovations Institute
  • Study coordinator: Hans Gregersen,, PhD
  • Email: hag@giome.org
  • Phone: 858-249-7400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.